86 Stocks Moving In Friday's Mid-Day Session

Gainers

• iBio, Inc. IBIO shares jumped 206.5% to $2.65 after jumping around 159% on Thursday. iBio disclosed a $100 million mixed securities offering.
• Ritter Pharmaceuticals Inc RTTR shares jumped 128% to $0.6467 after climbing over 35% on Thursday.
• Altimmune Inc ALT climbed 125% to $3.96. Altimmune reported completion of first development milestone toward a single-dose intranasal coronavirus vaccine.
• Dynatronics Corporation DYNT surged 121% to $2.6624 after climbing more than 24% on Thursday.
• Allied Healthcare Products, Inc. AHPI shares gained 107.5% to $32.20 after climbing around 322% on Thursday. The company manufactures emergency medical supplies and respiratory devices, including 'mass casualty' products, and has attracted investor interest amid the coronavirus outbreak.
• OpGen, Inc. OPGN shares gained 78.5% to $3.6399 after gaining around 38% on Thursday.
• Trillium Therapeutics Inc. TRIL shares rose 62.3% to $5.03 in sympathy with Forty Seven after Gilead Sciences approached the company with a takeover offer.
• Alpha Pro Tech, Ltd. APT jumped 39% to $35.08. Alpha Pro Tech shares jumped around 104% on Thursday after the company announced it has booked $14.1 million in orders for its N-95 face mask since Jan. 27, which it expects will be fulfilled.
• Novavax, Inc. NVAX rose 38.6% to $16.35 after gaining around 28% on Thursday. Shares of several vaccine companies are trading higher on growing global coronavirus fears.
• Correvio Pharma Corp CORV jumped 37.7% to $0.42.
• Titan Pharmaceuticals, Inc. TTNP gained 36% to $0.2860.
• Cytosorbents Corporation CTSO surged 33% to $6.98. CytoSorbents reported that shipment arrived in designated mainland China hospitals to treat cytokine storm in critically-ill patients with COVID-19 coronavirus infection.
• Datasea Inc. DTSS gained 32.2% to $2.75.
• Trinity Biotech plc TRIB rose 30.8% to $1.40 after climbing more than 12% on Thursday.
• Sangamo Therapeutics Inc SGMO rose 28% to $8.53. Sangamo and Biogen Inc announced a global licensing collaboration agreement for developing and commercializing ST-501 for tautopathies including Alzheimer's disease, ST-502 for synucleinopathies, including Parkinson's disease, a third undisclosed neuromuscular disease target, and upto nine additional undisclosed neurological disease targets. The company also reported better-than-expected Q4 EPS results and sales up from last year.
• Verastem Inc VSTM jumped 25.4% to $2.3950 after the company announced a strategic direction to accelerate the development of CH5126766 for the treatment of KRAS mutant solid tumors.
• Vaxart, Inc. VXRT shares rose 23.1% to $3.04 after surging around 50% on Thursday.
• MDC Partners Inc. MDCA gained 23% to $2.48 after reporting Q4 results.
• Forty Seven, Inc. FTSV surged 22.5% to $59.77 on reports of a takeover interest. Gilead Sciences, , which is contending with an aging AIDS franchise and a flailing NASH program, has made overtures to Forty Seven, according to a Bloomberg, citing people with knowledge of the information. Gilead reportedly is considering several options, including forging a partnership. The Bloomberg report said Forty Seven had received takeover interest from other companies as well.
• Lakeland Industries, Inc. LAKE shares rose 22.1% to $24.39 after surging 22.5% on Thursday.
• COMSCORE, Inc. SCOR rose 21.2% to $3.63 after the company reported better-than-expected Q4 EPS results.
• Penn Virginia Corporation PVAC surged 20.8% to $14.30 following strong quarterly sales.
• GenMark Diagnostics, Inc. GNMK gained 19% to $4.305. GenMark diagnostics site showed that company has coronavirus test.
• Farfetch Limited FTCH surged 17.4% to $11.14 after the company reported better-than-expected Q4 results.
• Chembio Diagnostics, Inc. CEMI jumped 15.6% to $4.58.
• Co-Diagnostics, Inc. CODX rose 14.7% to $18.30 after surging over 79% on Thursday. Co-Diagnostics reported a $4.2 million registered direct offering priced at the market at $9 per share on Thursday. Shares of several vaccine companies are trading higher on growing global coronavirus fears.
• Zynex, Inc. ZYXI gained 14.6% to $13.66 after reporting strong Q4 results.
• Owens & Minor, Inc. OMI surged 14.4% to $7.01.
• BOQI International Medical Inc. BIMI rose 13.8% to $4.8001.
• Nautilus, Inc. NLS surged 12.3% to $3.10.
• Rayonier Advanced Materials Inc. RYAM jumped 11.7% to $2.30.
• The Lovesac Company LOVE rose 11.3% to $8.79.
• Diamond Offshore Drilling, Inc DO gained 11.2% to $2.88 despite market downturn and weakness in oil.
• Guardion Health Sciences Inc GHSI gained 11.1% to $0.5221.
• Beyond Air, Inc. XAIR gained 10.9% to $8.11.
• Surface Oncology, Inc. SURF shares rose 10.9% to $2.9499.
• Chico's FAS, Inc. CHS climbed 10.8% to $4.0450 despite overall market downturn. The company early Thursday reported better-than-expected Q4 results and raised its quarterly dividend,
• Spectrum Pharmaceuticals, Inc. SPPI shares gained 10.8% to $2.66 following Q4 results.
• Briggs & Stratton Corporation BGG jumped 10% to $3.29.
• RealPage, Inc. RP shares gained 10% to $60.56 following better-than-expected quarterly results.
• Carrols Restaurant Group, Inc. TAST jumped 9.5% to $4.17.
• NeoPhotonics Corp NPTN shares rose 8.3% to $6.69 after the company reported better-than-expected Q4 sales results. The company also issued Q1 EPS guidance above estimates.
• Trade Desk Inc TTD rose 7.5% to $268.80 after the company reported better-than-expected Q4 EPS and sales results. The company also issued Q1 and FY20 sales guidance above estimates.

Check out these big penny stock gainers and losers

Losers

• Gulfport Energy Corporation GPOR shares dipped 44.4% to $0.5002 after reporting downbeat Q4 results.
• Tellurian Inc. TELL tumbled 40.1% to $2.20 as the global coronavirus spread continues to cause equities across sectors to sell off amid worsened economic outlook.
• Glaukos Corporation GKOS shares fell 30% to $43.05 after the company Q4 results. JP Morgan downgraded Glaukos from Overweight to Neutral and lowered the price target from $65 to $55.
• Tonix Pharmaceuticals Holding Corp TNXP fell 29.8% to $1.2150. Tonix Pharmaceuticals priced its $16 million common stock offering at $1.10 per share.
• Big Lots, Inc. BIG tumbled 29.3% to $15.87 after the company reported worse-than-expected Q4 results. The company also issued Q1 and FY20 earnings guidance below estimates. JP Morgan downgraded Big Lots from Neutral to Underweight and lowered the price target from $31 to $14.
• Novan Inc NOVN shares dipped 27.8% to $0.2455 after the company priced its 18.3 million share and warrant public offering.
• China Online Education Group COE fell 23.8% to $22.34 after dropping 15.8% on Thursday.
• Summit Midstream Partners, LP SMLP dropped 22.8% to $1.76 after reporting Q4 results.
• Vir Biotechnology, Inc. VIR fell 21.6% to $47.22 after gaining more than 72% on Thursday.
• SemiLEDs Corporation LEDS shares declined 18.8% to $2.08.
• Beyond Meat, Inc. BYND shares dipped 18.6% to $86.36. Beyond Meat reported weaker-than-expected earnings for its fourth quarter, while sales exceeded views.
• Wayfair Inc W fell 17% to $58.44 after reporting wider-than-expected Q4 loss.
• Metalla Royalty & Streaming Ltd. MTA dipped 16.4% to $3.96.
• Taronis Technologies Inc TRNX fell 16% to $0.2941.
• Eventbrite, Inc. EB dropped 15.8% to $14.34 following Q4 results. RBC Capital downgraded Eventbrite from Outperform to Sector Perform.
• Codexis, Inc. CDXS fell 15% to $11.28 following Q4 results.
• Equinox Gold Corp. EQX fell 14.5% to $6.91 after dropping 10% on Thursday.
• SG Blocks, Inc. SGBX shares dipped 14.5% to $1.82.
• Addus HomeCare Corporation ADUS shares declined 14.4% to $76.64.
• Iterum Therapeutics plc ITRM fell 14.2% to $2.4625.
• OptimizeRx Corporation OPRX tumbled 14.2% to $8.61 after reporting Q4 results.
• Harmony Gold Mining Company Limited HMY fell 13.6% to $3.2725.
• Mesoblast Limited MESO fell 12.5% to $7.00.
• Americas Gold and Silver Corporation USAS shares declined 12% to $2.20.
• Switch, Inc. SWCH fell 11.9% to $14.16 following Q4 results.
• CytomX Therapeutics, Inc. CTMX shares declined 11.6% to $6.30. Nomura lowerd the price target on CytomX Therapeutics from $22 to $15.
• Sandstorm Gold Ltd. SAND dipped 11.5% to $6.02.
• Protalix BioTherapeutics, Inc. PLX shares dipped 11.4% to $3.34 after rising 6.2% on Thursday.
• Great Elm Capital Corporation GECC tumbled 11.2% to $6.58.
• Intevac, Inc. IVAC fell 10.8% to $5.42.
• iQIYI, Inc. IQ dipped 10.5% to $21.86 after the company reported Q4 earnings results.
• Gannett Co., Inc. GCI fell 10.3% to $4.3050 as the global coronavirus spread continues to cause equities across sectors to sell off amid worsened economic outlook.
• Aethlon Medical, Inc. . AEMD fell 10% to $2.6998 after gaining more than 58% on Thursday.
• Hamilton Lane Incorporated HLNE dropped 10% to $57.95.
• Tocagen Inc TOCA fell 10% to $1.45 after the company reported Q4 results.
• VMware, Inc. VMW fell 7.7% to $125.23 after the company reported worse-than-expected Q4 EPS results.
• Mechel PAO MTL fell 7.5% to $2.5150 after declining over 11% on Thursday.
• Anheuser Busch Inbev NV BUD fell 7.4% to $55.73 after Bryan Garnier downgraded the stock from Buy to Neutral.
• Innate Pharma S.A. IPHA fell 7.3% to $7.02.
• Kirkland Lake Gold Ltd. KL dipped 7.3% to $31.33 after dropping more than 7% on Thursday.
• TRACON Pharmaceuticals Inc TCON fell 6.8% to $2.75 after the company reported Q4 results.
• SmileDirectClub, Inc. SDC fell 6.5% to $7.30.
• Dell Technologies Inc DELL fell 6% to $40.99 following Q4 results.